Insider Trading History of Gallagher Brian M. Jr.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gallagher Brian M. Jr. since 2017. This trader's CIK number is 1709976. At the time of last reporting, Gallagher Brian M. Jr. was the Director of Effector Therapeutics, Inc.. (stock ticker symbol EFTR). Also see all insider trading activities at Effector Therapeutics, Inc..

Note that in the past Gallagher Brian M. Jr. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aileron Therapeutics Inc (ALRN) by Gallagher Brian M. Jr.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 ALRN 273,333 $4,099,995 0 $0 0 $0

Yearly summary of insider trading at Effector Therapeutics, Inc. (EFTR) by Gallagher Brian M. Jr.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 EFTR 30,000 $47,700 0 $0 0 $0

Yearly summary of insider trading at Translate Bio, Inc. (TBIO) by Gallagher Brian M. Jr.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 TBIO 269,230 $3,499,990 0 $0 0 $0


Insider trading activities at 3 companies by Gallagher Brian M. Jr.:

1. Aileron Therapeutics Inc (ALRN)

2. Effector Therapeutics, Inc. (EFTR)

3. Translate Bio, Inc. (TBIO)

Table 1. Insider trading of Aileron Therapeutics Inc (ALRN) by Gallagher Brian M. Jr.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-07-05 ALRN Buy 273,333 15.00 4,099,995

Table 2. Insider trading of Effector Therapeutics, Inc. (EFTR) by Gallagher Brian M. Jr.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-23 EFTR Buy 30,000 1.59 47,700

Table 3. Insider trading of Translate Bio, Inc. (TBIO) by Gallagher Brian M. Jr.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-02 TBIO Buy 269,230 13.00 3,499,990

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gallagher Brian M. Jr. (Director of Effector Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.